Appendix E - National Coverage Determinations Manual / Nebulized Beta Adrenergic Agonist Therapy for Lung Diseases 200.2

Why This Topic Matters

Coverage policy articles like this help organizations determine whether a service is governed by national Medicare policy or left to local contractor determination. That matters for reimbursement planning, compliance review, and policy interpretation for respiratory therapy services.

Article Sections

1. General

   Provides background on lung diseases and the use of bronchodilator therapy, with discussion of the medication class and route of administration in broad terms.

2. Nationally Covered Indications

   States the covered-indications status for this policy section.

3. Nationally Non-Covered Indications

   States the non-covered-indications status for this policy section.

4. Other

   Describes the Medicare coverage determination outcome, cites the governing statutory and legal framework, and notes the review timing.